PDS Biotechnology Corp Paid-in-Kind Interest
PDS Biotechnology Corp (PDSB) reported Paid-in-Kind Interest of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-18.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2021-03-18
- PDS Biotechnology Corp paid-in-kind interest for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- PDS Biotechnology Corp paid-in-kind interest for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- PDS Biotechnology Corp paid-in-kind interest for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- PDS Biotechnology Corp paid-in-kind interest for the quarter ending 2018-03-31 was $405.28K, a 337.91% increase year-over-year.
- PDS Biotechnology Corp paid-in-kind interest for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- PDS Biotechnology Corp paid-in-kind interest for fiscal 2019 was $32.95K, a 91.87% decline from fiscal 2018.
- PDS Biotechnology Corp paid-in-kind interest for fiscal 2018 was $405.28K, a 11.37% increase from fiscal 2017.
- PDS Biotechnology Corp paid-in-kind interest for fiscal 2017 was $363.91K, a 106.87% increase from fiscal 2016.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-18 | |||
| 2019-12-31 | $32.95K 10-K · filed 2021-03-18 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $0.00 derived: sum of 2 quarters · filed 2019-02-21 | $0.00 derived: sum of 3 quarters · filed 2019-02-21 | $405.28K 10-K · filed 2019-02-21 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $0.00 derived: sum of 2 quarters · filed 2018-11-01 | $405.28K 10-Q · filed 2018-11-01 | $494.66K derived: sum of 4 quarters · filed 2019-02-21 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $405.28K 10-Q · filed 2018-08-01 | $494.66K derived: sum of 3 quarters · filed 2019-02-21 | $585.12K derived: sum of 4 quarters · filed 2019-02-21 |
| 2018-03-31 | $405.28K 10-Q · filed 2018-05-01 | $494.66K derived: sum of 2 quarters · filed 2019-02-21 | $585.12K derived: sum of 3 quarters · filed 2019-02-21 | $676.64K derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-12-31 | $89.38K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $179.84K derived: sum of 2 quarters · filed 2019-02-21 | $271.36K derived: sum of 3 quarters · filed 2019-02-21 | $363.91K 10-K · filed 2019-02-21 |
| 2017-09-30 | $90.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $181.98K derived: sum of 2 quarters · filed 2018-11-01 | $274.53K 10-Q · filed 2018-11-01 | $368.08K derived: sum of 4 quarters · filed 2018-11-01 |
| 2017-06-30 | $91.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $184.07K 10-Q · filed 2018-08-01 | $277.62K derived: sum of 3 quarters · filed 2018-08-01 | $343.00K derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-03-31 | $92.55K 10-Q · filed 2018-05-01 | $186.10K derived: sum of 2 quarters · filed 2018-05-01 | $251.48K derived: sum of 3 quarters · filed 2018-05-01 | $259.50K derived: sum of 4 quarters · filed 2018-05-01 |
| 2016-12-31 | $93.55K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $158.93K derived: sum of 2 quarters · filed 2018-03-01 | $166.95K derived: sum of 3 quarters · filed 2018-03-01 | $175.91K 10-K · filed 2018-03-01 |
| 2016-09-30 | $65.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $73.40K derived: sum of 2 quarters · filed 2017-11-01 | $82.36K 10-Q · filed 2017-11-01 | $92.21K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $8.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $16.98K 10-Q · filed 2017-08-01 | $26.84K derived: sum of 3 quarters · filed 2018-03-01 | $36.99K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $8.96K 10-Q · filed 2017-05-03 | $18.81K derived: sum of 2 quarters · filed 2018-03-01 | $28.96K derived: sum of 3 quarters · filed 2018-03-01 | $39.11K derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $9.85K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $20.00K derived: sum of 2 quarters · filed 2018-03-01 | $30.16K derived: sum of 3 quarters · filed 2018-03-01 | $38.52K 10-K · filed 2018-03-01 |
| 2015-09-30 | $10.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $20.30K derived: sum of 2 quarters · filed 2016-11-01 | $28.67K 10-Q · filed 2016-11-01 | $33.45K derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-06-30 | $10.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $18.52K 10-Q · filed 2016-08-03 | $23.30K derived: sum of 3 quarters · filed 2017-03-02 | |
| 2015-03-31 | $8.36K 10-Q · filed 2016-05-03 | $13.15K derived: sum of 2 quarters · filed 2017-03-02 | ||
| 2014-12-31 | $4.79K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $6.38K 10-K · filed 2017-03-02 | ||
| 2014-09-30 | $1.60K 10-Q · filed 2015-11-06 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |